NL8500928A - Nieuwe geneesmiddelcombinaties met synergistisch effect en werkwijze voor de bereiding ervan. - Google Patents

Nieuwe geneesmiddelcombinaties met synergistisch effect en werkwijze voor de bereiding ervan. Download PDF

Info

Publication number
NL8500928A
NL8500928A NL8500928A NL8500928A NL8500928A NL 8500928 A NL8500928 A NL 8500928A NL 8500928 A NL8500928 A NL 8500928A NL 8500928 A NL8500928 A NL 8500928A NL 8500928 A NL8500928 A NL 8500928A
Authority
NL
Netherlands
Prior art keywords
preparation
antibiotic
treatment
weight ratio
composition according
Prior art date
Application number
NL8500928A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hajdusagi Agraripari Egyesules
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU122584A external-priority patent/HU191399B/hu
Priority claimed from HU122684A external-priority patent/HU190952B/hu
Priority claimed from HU152784A external-priority patent/HU190958B/hu
Application filed by Hajdusagi Agraripari Egyesules filed Critical Hajdusagi Agraripari Egyesules
Publication of NL8500928A publication Critical patent/NL8500928A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8500928A 1984-03-28 1985-03-28 Nieuwe geneesmiddelcombinaties met synergistisch effect en werkwijze voor de bereiding ervan. NL8500928A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
HU122584A HU191399B (en) 1984-03-28 1984-03-28 Process for the production of new compound medicine of synergic effect
HU122684 1984-03-28
HU122584 1984-03-28
HU122684A HU190952B (en) 1984-03-28 1984-03-28 Process for the production of new compound medicines of syneric effect, suitable for treating ureteral, respiratory and other infections of domestic animals
HU152784 1984-04-20
HU152784A HU190958B (en) 1984-04-20 1984-04-20 Process for producing new pharmaceutical compositions of synergetic activity for treating infections of domestic animals by protozoa and bacteria

Publications (1)

Publication Number Publication Date
NL8500928A true NL8500928A (nl) 1985-10-16

Family

ID=27269952

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500928A NL8500928A (nl) 1984-03-28 1985-03-28 Nieuwe geneesmiddelcombinaties met synergistisch effect en werkwijze voor de bereiding ervan.

Country Status (11)

Country Link
US (1) US4650790A (es)
AT (1) AT388100B (es)
BE (1) BE902010A (es)
CH (1) CH664285A5 (es)
DE (1) DE3511307A1 (es)
ES (1) ES8607728A1 (es)
FR (1) FR2561920B1 (es)
GB (1) GB2159409B (es)
LU (1) LU85823A1 (es)
NL (1) NL8500928A (es)
SE (1) SE8501532L (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199682B (en) * 1988-04-01 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producin synergetic veterinary composition
EP0585514B1 (en) * 1992-01-09 1998-10-07 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
EP0597167B1 (en) * 1992-08-11 1998-10-14 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana Veterinary preparation containing an antibiotic mixture of gentamicin and lincomycin as an additive to drinking water or animal feed and its use in pig breeding
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
FR2761074B1 (fr) 1997-03-24 1999-05-28 Exsymol Sa Composes a base de silicium biologiquement actifs sous forme solide
US20100197727A1 (en) * 2005-06-28 2010-08-05 Koenraad Jozef Lodewijk Marcel Andries Quinoline Derivatives as Antibacterial Agents
CA3046085A1 (en) * 2016-12-09 2018-06-14 Enbiotix, Inc. Aminoglycoside potentiation for treatment of pulmonary bacterial infection
WO2020031083A1 (en) * 2018-08-06 2020-02-13 KHAN, Khalid Antimicrobial formulations comprising vancomycin or tobramycin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799620A (en) * 1956-06-29 1957-07-16 Rutgers Res And Educational Fo Neomycin and process of preparation
US2931798A (en) * 1956-09-05 1960-04-05 Umezawa Hamao Kanamycin and processes for the preparation thereof
BE756856A (fr) * 1969-09-30 1971-03-01 Chinoin Gyogyszer Es Vegyeszet Compositions antibiotiques nouvelles possedant un effet therapeutique accru et leur preparation
CH551965A (de) * 1970-06-22 1974-07-31 Scherico Ltd Verfahren zur herstellung antibiotisch wirksamer verbindungen.
US3987194A (en) * 1975-05-12 1976-10-19 E. R. Squibb & Sons, Inc. Use of pleuromutilin derivatives for the treatment of swine dysentery
CH627940A5 (de) * 1976-12-23 1982-02-15 Sandoz Ag Kokzidiostatisches kombinationspraeparat.
GB2072012B (en) * 1980-03-14 1984-07-25 Squibb & Sons Inc Veterinary compositions containing pleuromutilin derivatives

Also Published As

Publication number Publication date
US4650790A (en) 1987-03-17
FR2561920A1 (fr) 1985-10-04
DE3511307A1 (de) 1985-10-10
SE8501532D0 (sv) 1985-03-28
AT388100B (de) 1989-04-25
FR2561920B1 (fr) 1989-10-27
ES8607728A1 (es) 1986-06-16
GB2159409B (en) 1988-08-10
GB2159409A (en) 1985-12-04
ES541694A0 (es) 1986-06-16
CH664285A5 (de) 1988-02-29
BE902010A (fr) 1985-09-25
LU85823A1 (fr) 1986-10-06
SE8501532L (sv) 1985-09-29
ATA89485A (de) 1988-10-15
GB8508000D0 (en) 1985-05-01

Similar Documents

Publication Publication Date Title
Enginler et al. Comparison of intramammary ozone administration doses in dairy cows with clinical mastitis
WO2016204169A1 (ja) 牛の泌乳期の甚急性又は急性乳房炎に対する治療剤、並びに治療方法
NL8500928A (nl) Nieuwe geneesmiddelcombinaties met synergistisch effect en werkwijze voor de bereiding ervan.
CN114129547B (zh) 香芹酚在提高耐甲氧西林金黄色葡萄球菌对β-内酰胺类抗生素敏感性方面的应用
KR100707988B1 (ko) 젖소 유방염 치료 및 예방을 위한 복합항생제 조성물
GB2589856A (en) Composition for use of reducing SCC and subsequent mastitis in dairy cows
King Streptococcus uberis: a review of its role as a causative organism of bovine mastitis. II. Control of infection
US4140766A (en) Method and composition for therapy and control of bovine mastitis
JP5322649B2 (ja) セフキノム組成物およびその使用方法
US2728704A (en) Therapeutic composition effective against mastitis
EP1262185A1 (en) Synergistic antibiotic compositions
CN113476431A (zh) 一种环三酮衍生物在制备动物用药中的应用
CN106668010A (zh) 一种用于治疗细菌性奶牛乳房炎的药物组合物及其制备方法
Aungier et al. A study of the efficacy of intramammary antibiotics in the treatment of clinical mastitis
AU652443B2 (en) Treatment of mastitis
RU2028798C1 (ru) Способ профилактики мастита у коров
RU2738010C1 (ru) Способ лечения и профилактики субклинического мастита у коров
Long et al. Depletion of antibiotics from the mammary gland of goats
Cızmecı et al. Determination of the effects of different dry cow therapy on udder health in dairy cows.
NL8501198A (nl) Nieuwe geneesmiddelen met antimicrobiele werking en werkwijze voor de bereiding ervan.
RU2593809C1 (ru) Композиционный препарат для профилактики эшерихиозного гастроэнтерита поросят
RU2514647C1 (ru) Композиция для лечения инфекций бактериальной этиологии у животных
HU191399B (en) Process for the production of new compound medicine of synergic effect
Hoge et al. The effect of sulfanilamide therapy upon bovine mastitis as indicated by laboratory tests
Cairns et al. Thiabendazole as an anthelmintic against Hyostrongylus rubidus and Oesophagostomum dentatum in pigs

Legal Events

Date Code Title Description
BV The patent application has lapsed